首页 | 本学科首页   官方微博 | 高级检索  
     

芪苈强心胶囊治疗慢性心力衰竭作用机制研究进展
引用本文:赵齐飞,李红蓉,尹玉洁,常丽萍,贾振华. 芪苈强心胶囊治疗慢性心力衰竭作用机制研究进展[J]. 天津中医药, 2019, 36(4): 313-318
作者姓名:赵齐飞  李红蓉  尹玉洁  常丽萍  贾振华
作者单位:河北医科大学研究生学院, 石家庄 050017;河北医科大学附属以岭医院, 国家中医药管理局中医络病学重点学科, 石家庄 050091,河北医科大学研究生学院, 石家庄 050017;河北医科大学附属以岭医院, 国家中医药管理局中医络病学重点学科, 石家庄 050091,河北医科大学附属以岭医院, 国家中医药管理局中医络病学重点学科, 石家庄 050091;河北以岭医药研究院, 国家中医药管理局重点研究室, 石家庄 050035,河北以岭医药研究院, 国家中医药管理局重点研究室, 石家庄 050035;石家庄以岭药业股份有限公司, 络病研究与创新中药国家重点实验室, 石家庄 050035,河北医科大学研究生学院, 石家庄 050017;河北医科大学附属以岭医院, 国家中医药管理局中医络病学重点学科, 石家庄 050091;河北以岭医药研究院, 国家中医药管理局重点研究室, 石家庄 050035
基金项目:国家重点研发计划“中医药现代化研究”重点专项资助项目(2017YFC1700500);河北省自然科学基金资助项目(H2018106043)。
摘    要:慢性心力衰竭(慢性心衰)是心血管事件链中的关键环节,以中医脉络学说为指导研发的创新中药芪苈强心胶囊对慢性心衰具有良好疗效,研究表明该药能够增强心肌收缩力,利尿,抑制神经内分泌系统过度激活,抑制炎症反应、心肌纤维化、细胞凋亡和自噬,改善心肌能量代谢,促进血管新生,改善内皮功能,从而抑制心室重构,延缓慢性心衰进程。探讨芪苈强心胶囊治疗慢性心衰的作用及机制,有利于从多靶点、多通道发挥该药治疗作用,同时为心血管事件链中其他难治性疾病提供更广阔的治疗思路,对提高中医药治疗心血管疾病具有重大的理论与临床意义。

关 键 词:慢性心力衰竭  脉络学说  芪苈强心胶囊  作用机制
收稿时间:2019-01-02

Research progress on the effect and mechanism of Qili Qiangxin Capsule in treating chronic heart failure
ZHAO Qifei,LI Hongrong,YIN Yujie,CHANG Liping and JIA Zhenhua. Research progress on the effect and mechanism of Qili Qiangxin Capsule in treating chronic heart failure[J]. Tianjin Journal of Traditional Chin Medicine, 2019, 36(4): 313-318
Authors:ZHAO Qifei  LI Hongrong  YIN Yujie  CHANG Liping  JIA Zhenhua
Affiliation:Graduate School, Hebei Medical University, Shijiazhuang 050017, China;Affiliated Yiling Hospital of Hebei Medical University, Key Disciplines of State Administration of TCM for Collateral Disease, Shijiazhuang 050091, China,Graduate School, Hebei Medical University, Shijiazhuang 050017, China;Affiliated Yiling Hospital of Hebei Medical University, Key Disciplines of State Administration of TCM for Collateral Disease, Shijiazhuang 050091, China,Affiliated Yiling Hospital of Hebei Medical University, Key Disciplines of State Administration of TCM for Collateral Disease, Shijiazhuang 050091, China;Hebei Yiling Pharmaceutical Research Institute, Key Laboratory of State Administration of TCM, Shijiazhuang 050035, China,Hebei Yiling Pharmaceutical Research Institute, Key Laboratory of State Administration of TCM, Shijiazhuang 050035, China;Shijiazhuang Yiling Pharmaceutical Co., Ltd, National Key Laboratory of Collateral Disease Research and Innovative Chinese Medicine, Shijiazhuang 050035, China and Graduate School, Hebei Medical University, Shijiazhuang 050017, China;Affiliated Yiling Hospital of Hebei Medical University, Key Disciplines of State Administration of TCM for Collateral Disease, Shijiazhuang 050091, China;Hebei Yiling Pharmaceutical Research Institute, Key Laboratory of State Administration of TCM, Shijiazhuang 050035, China
Abstract:Chronic heart failure is a key part of cardiovascular continuum. Under the guidance of the theory of vessel-collateral doctrine,the present study proposes therapeutic benefits of Qili Qiangxin Capsules,an innovative Chinese medicine,on chronic heart failure. The studies show that multiple targets of the drug on chronic heart failure,including enhancing myocardial systole,promoting urine excretion,inhibiting excessive activation of the neuroendocrine system,preventing ventricular remodeling by inhibiting inflammatory response,myocardial fibrosis,apoptosis and autophagy,enhancing myocardial energy metabolism,promoting angiogenesis and improving endothelial function. To investigate the effect and mechanism of the drug is beneficial to the treatment of chronic heart failure through multiple targets or signaling pathways. Meanwhile,it provides new insights to further understand other refractory diseases in the cardiovascular continuum,and it also has an important theoretical and practical significance in enhancing prevention and therapeutic effect of traditional Chinese medicine for these diseases.
Keywords:chronic heart failure  vessel-collateral doctrine  Qili Qiangxin Capsule  the effect and mechanism
本文献已被 CNKI 等数据库收录!
点击此处可从《天津中医药》浏览原始摘要信息
点击此处可从《天津中医药》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号